Dr. Chao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9415 Campus Point Dr
La Jolla, CA 92093Phone+1 858-434-6290
Summary
- I am a retina surgeon and clinician-scientist focused on translational research and innovation in retinal disease.
Education & Training
University of California (San Francisco)Fellowship, Surgical Retina and Vitreous, 2014 - 2016
University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 2011 - 2014
Santa Clara Valley Medical CenterInternship, Transitional Year, 2010 - 2011
Stanford University School of MedicineClass of 2010
Certifications & Licensure
CA State Medical License 2014 - 2026
NJ State Medical License 2021 - 2025- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Allergan FIRST Program Participant Allergan
- Emerging Vision Scientist AEVR, 2016
- William F. Hoyt Teaching Award UCSF Ophthalmology, 2016
- Join now to see all
Publications & Presentations
PubMed
- 17 citationsSGLT2 Inhibitor–Induced Low-Grade Ketonemia Ameliorates Retinal Hypoxia in Diabetic Retinopathy—A Novel HypothesisSunder Mudaliar, Christopher J. Hupfeld, Daniel L Chao
The Journal of Clinical Endocrinology and Metabolism. 2021-04-23 - 2 citationsResearch Funding, Income, and Career Satisfaction Among Clinician-Scientists in Ophthalmology in the United States.Alexander M. Rusakevich, Nicholas J. Protopsaltis, Rajesh C. Rao, Daniel L. Chao, Glenn Yiu
American Journal of Ophthalmology. 2021-04-06 - Comment on Sex Differences in the Repair of Retinal Detachments in the United States.Michael J. Venincasa, Jayanth Sridhar, Nika Bagheri, Daniel L. Chao, Priya Vakharia
American Journal of Ophthalmology. 2021-04-01
Press Mentions
Pain Control After Intravitreal Injection Using Topical Nepafenac 0.3% or Pressure Patching: A Randomized, Placebo-Controlled TrialApril 29th, 2020
Current Practice Preferences and Safety Protocols for Intravitreal Injection of Anti-Vascular Endothelial Growth Factor AgentsMarch 22nd, 2020
Researchers Identify Gene with Functional Role in Aging of EyeJanuary 15th, 2020- Join now to see all
Grant Support
- ASCRS Foundation Research GrantASCRS2013–2014
Professional Memberships
- Member
- Member
Other Languages
- Chinese (Mandarin), Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
